Misclassification of Both Influenza Infection and Oseltamivir Exposure Status in Administrative Data

JAMA Pediatr. 2024 Feb 1;178(2):201-203. doi: 10.1001/jamapediatrics.2023.5731.

Authors

Hannah K Bassett¹, Eric R Coon², Jonathan M Mansbach³, Kathleen Snow³, Maya Wheeler², Alan R Schroeder¹

Affiliations

¹ Division of Hospital Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California.
² Division of Hospital Medicine, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City.
³ Division of General Pediatrics, Department of Pediatrics, Harvard University School of Medicine, Boston, Massachusetts.

PMID: 38147329
PMCID: PMC10751652 (available on 2024-12-26)
DOI: 10.1001/jamapediatrics.2023.5731

No abstract available

Plain language summary

This cross-sectional study examines documented hospitalization for influenza and administration of neuraminidase inhibitors in US children.

MeSH terms

Antiviral Agents / therapeutic use
Enzyme Inhibitors
Humans
Influenza, Human* / drug therapy
Influenza, Human* / epidemiology
Neuraminidase / therapeutic use
Oseltamivir* / therapeutic use

Substances

Oseltamivir
Antiviral Agents
Enzyme Inhibitors
Neuraminidase